Reproductive and Developmental Biology

The Korean Society of Animal Reproduction (한국동물번식학회)
권호 표지

Changes of Gelatinolytic Activity in Human Amniotic Membrane-Derived Mesenchymal Stem Cells during Culture in Hepatogenic Medium

  • Park S. (Department of Biotechnology, College of Natural Sciences, Seoul Women's University) ;
  • Kook M. (Department of Biotechnology, College of Natural Sciences, Seoul Women's University) ;
  • Kim H. (Department of Biotechnology, College of Natural Sciences, Seoul Women's University)
  • Published : 2005.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

The present study was conducted to investigate gelatinolytic activities in HAM and to determine whether there are any changes in gelatinolytic activity profiles when the cells are cultured in hepatogenic medium. Placenta was obtained during caesarean section of the volunteers, with informed consent. HAM were isolated from amniotic membrane using collagenase type A HAM were cultured in hepatogenic medium for 3 weeks and the conditioned media were obtained at day 7, 14 and 21. The zymographic pattern of gelatinolytic activity of the HAM did not undergo a change during passages. When the HAM were cultured in a fibronectin-coated dishes in a hepatogenic medium, there was no significant difference of the gelatinase pattern between before and after culture. However, when bFGF was added to the culture, a dramatic increase of 62kDa and 59kDa gelatinases was observed. Interestingly, when ITS instead of FN was present, HAM-conditioned medium also showed a similar increase of both gelatinases. Immunoblotting analysis demonstrated that both 62kDa and 59kDa gelatinases were the active form of MMP-2 resulting from the turnover of MMP-2 proform. Futher study will be necessary to determine the relationship between bFGF and active MMP-2 during hepatogenesis of HAM.

Keywords

References

  1. Baird A, Ling N (1987): Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase- like enzymes in the neovascular response. Biochem Biophys Res Commun 142:428-435 https://doi.org/10.1016/0006-291X(87)90292-0
  2. Basbaum CB, Werb Z (1996): Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell BioI 8:731-738 https://doi.org/10.1016/S0955-0674(96)80116-5
  3. Benyon RC, Hovell CJ, Da Gaca M, Jones EH, Iredale JP, Arthur MJ (1999): Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 30:977-986 https://doi.org/10.1002/hep.510300431
  4. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA (1993): Matrix metalloproteinases: A review. Crit Rev Oral Bio Med 4:197-250 https://doi.org/10.1177/10454411930040020401
  5. Casey ML, MacDonald PC (1996): Interstitial collagen synthesis and processing in human amnion: a property of the mesenchymal cells. BioI Reprod 55:1253-1260 https://doi.org/10.1095/biolreprod55.6.1253
  6. Collolly DT, Stoddard BL, Harakas NK, Feder J (1987): Human fibroblast-derived growth factor is mitogen and chemoattractant for endothelial cells. Biochem Biophys Res Commun 144:705-712 https://doi.org/10.1016/S0006-291X(87)80022-0
  7. Cronauer MY, Schulz WA, Seifert HH, Ackermann R, Burcha M (2003): Fibroblast growth factors and their receptors in urological cancers: Basic research and clinical implications. European Urology 43:309-319 https://doi.org/10.1016/S0302-2838(03)00005-8
  8. Franke FE, Von Georgi R, Zygmunt M, Munstsde K (2003): Association between fibronectin expression and prognosis in ovarian carcinoma. Anticancer Res 23: 4261-4267
  9. Gohji K, Nakajima M, Fabra A, Bucana CD, Eschenbach AC, Tsuruo T, Fidler IJ (1994): Regulation of gelatinase production in metastatic renal cell carcinoma by organ- specific fibroblasts. Jpn J Cancer Res 85:152-160 https://doi.org/10.1111/j.1349-7006.1994.tb02076.x
  10. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y(1991): Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51: 6180-6184
  11. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakuragawa N (2000): Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp Neurol 165:27-34 https://doi.org/10.1006/exnr.2000.7449
  12. Kim J, Kim J, Kim H, Lee SJ, Yoon YD, Kwon HC, Kim SK (2003): Selective processing of a follicular matrix metalloproteinase-2 isoform by human oviducal fluid. Reprod Fertil Dev 15:141-147 https://doi.org/10.1071/RD02082
  13. Koizumi N, Inatomi T, Quantock AJ, Fullwood NJ, Dota A and Kinoshita S (2000): Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 19: 65-71 https://doi.org/10.1097/00003226-200001000-00013
  14. Liu JF, Crepin M, Liu JM, Barritault D, Ledoux D (2002): FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293: 1174-1182 https://doi.org/10.1016/S0006-291X(02)00350-9
  15. Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK (1996): Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res 56:2837-2843
  16. Mars WM, Liu ML, Kitson RP, Goldfarb RH. Gabauer MK, Michalopoulos GK (1995): Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 21:1695-1701
  17. Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, Chihara K, Karnidono S (1996): Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res 56:2440-2445
  18. Miyake H, Yoshimura K, Hara I, Eto H, Arakawa S, Kamidono S (1997): Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. J Urol 157:2351-2355 https://doi.org/10.1016/S0022-5347(01)64779-7
  19. Nagase H (1997): Activation mechanisms of matrix metallproteinases. BioI Chem 378:151-160
  20. Pickering JG, Ford CM, Tang B, Chow LH (1997): Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arterioscler Thromb Vase BioI 17:475-482 https://doi.org/10.1161/01.ATV.17.3.475
  21. Pankov R, Yamada KM (2002): Fibronectin at a glance. J Cell Sci 115:3861-3863 https://doi.org/10.1242/jcs.00059
  22. Pintucci G, Yu PJ, Sharony R, Baumann FG, Saponara F, Frasca A, Galloway AC, Moscatelli D, Mignatti P (2003): Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-$2^{-/-}$ microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK- 1/2). J Cell Biochem 90:1015-1025 https://doi.org/10.1002/jcb.10721
  23. Powers CJ, McLeskey SW, Konisih M, Ithoh N, (2000): Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochem Biophys Acta 1492: 203-206
  24. Rebmann V, Pfeiffe K, PassIer M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H (1999): Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53:14-22 https://doi.org/10.1034/j.1399-0039.1999.530102.x
  25. Rooney lA, Morgan BP (1992): Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid. Immunology 76:541-547
  26. Saji Y, Tamura S, Yoshida Y, Kiso S, Iizuka AS, Matsumoto H, Kawasaki T, Kamada Y, Matsuzawa Y, Shinomura Y (2004): Basic fibroblast growth factor promotes the trans-differentiation of mouse bone marrow cells into hepatic lineage cells via multiple liver-enriched transcription factors. J Hepatol 41:545-551 https://doi.org/10.1016/j.jhep.2004.06.017
  27. Sakuragawa N, Kakinuma K, Kikuchi A, Okano H, Uchida S, Kamo I, Kobayashi M, Yokoyama Y (2005): Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 78:208-214 https://doi.org/10.1002/jnr.20257
  28. Sapienza P, di Marzo L, Borrelli V, Sterpetti AV, Mingoli A, Piagnerelli R, Cavallaro A (2004): Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression. Eur J Vase Endovasc Surg 28:89-97 https://doi.org/10.1016/j.ejvs.2004.02.022
  29. Schlessinger J (2000): Cell signaling by receptor tyrosine kinases. Cell 103:211-225 https://doi.org/10.1016/S0092-8674(00)00114-8
  30. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, Leuvik T, Johnson S, Hu WS, Verfaillie CM (2002): Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109:1291-1302 https://doi.org/10.1172/JCI0215182
  31. Seiji T, Hirohiko I, Peng Z, Toshihiro A, Toshio N (2004): Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct 29:73-84 https://doi.org/10.1247/csf.29.73
  32. Stamekovic I (2000): Extracellular matrix remodeling: the role of matrix metalloproteinases. J Pathol 277: 28554-28563
  33. Taylor WR, Greenberg AH, Turley EA, Wright, J (1993): Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF. Exp Cell Res 204: 295-301 https://doi.org/10.1006/excr.1993.1036
  34. Trelford JD, Trelford-Sauder M (1979): The amnion in surgery, past and present. Am J Obstet Gynecol 134: 833-845 https://doi.org/10.1016/0002-9378(79)90957-8
  35. Udayakumar TS, Klein RD, Maliner MS, Nagle RB, Bowden GT (2001): Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors. Int J Cancer 91:187-192 https://doi.org/10.1002/1097-0215(200002)9999:9999<::AID-IJC1023>3.3.CO;2-N
  36. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M Akaike T, Kato K, Konishi I, Nikaido T (2003): Human amnionisolated cells nonnalize blood glucose in streptozotocin- induced diabetic mice. Cell Transplant 12:545-552 https://doi.org/10.3727/000000003108747000
  37. Werb Z, Mainardi CL, Vater CA, Harris ED Jr (1997): Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med 296:1017-1023 https://doi.org/10.1056/NEJM197705052961801
  38. Zhang J, Zhi H, Zhou C, Ding F, Luo A, Zhang X, Sun Y, Wang X, Wu M, Lui Z (2005): Up-regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the Erk pathway. J Pathol 207:402-409 https://doi.org/10.1002/path.1846
  39. Zhao P, Ise H, Hcingo M, Ota M Konishi I, Nikaido T (2005): Human amniotic mesenchymal cells have some characteristics of cardiomyoeytes Transplantation 79: 528-535